g6pd activator administration (MedChemExpress)
Structured Review

G6pd Activator Administration, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/g6pd+activator+administration/Glucose-6-phosphate+dehydrogenase%2C+Microorganism/pm38875958-70-1-13
Average 93 stars, based on 2 article reviews
Images
1) Product Images from "Glucose-6-phosphate dehydrogenase alleviates epileptic seizures by repressing reactive oxygen species production to promote signal transducer and activator of transcription 1-mediated N-methyl-d-aspartic acid receptors inhibition."
Article Title: Glucose-6-phosphate dehydrogenase alleviates epileptic seizures by repressing reactive oxygen species production to promote signal transducer and activator of transcription 1-mediated N-methyl-d-aspartic acid receptors inhibition.
Journal: Redox biology
doi: 10.1016/j.redox.2024.103236
Figure Legend Snippet: Fig. 1. Expression and functionality of pivotal enzymes in the glycolytic and pentose phosphate pathways. (a–d) Representative immunoblots (a, c) and quantification (b, d) of metabolism enzymes in the glycolysis and pentose phosphate pathways from the cortex and hippocampus of sham and chronic epileptic mice (n = 6). Data are presented as means ± SEM. **P < 0.01, ***P < 0.001, unpaired two-tailed Student’s t-test. (e) Quantitative real-time polymerase chain reaction analysis of the expression of G6pd mRNA in the hippocampus at different time points after induction of status epilepticus (SE) (n = 5). Data are presented as means ± SEM. **P < 0.01, ***P < 0.001, one-way ANOVA with Tukey’s post hoc test. (f) Relative enzyme activity of G6PD in the hippocampus at different time points after induction of SE (n = 3). Data are presented as means ± SEM. **P < 0.01, ***P < 0.001, one-way ANOVA with Tukey’s post hoc test.
Techniques Used: Expressing, Western Blot, Two Tailed Test, Real-time Polymerase Chain Reaction, Activity Assay
Figure Legend Snippet: Fig. 2. Localization of G6PD in epileptic brain tissues. (a–b) Immunostaining for G6PD with neuron-specific nucleoprotein (NeuN), glial fibrillary acidic protein (GFAP), and ionized calcium-binding adapter molecule 1 (Iba-1) in the sham and kainic acid (KA) groups at 28 d. Scale bars: 50 μm. (b–c) Quantitative analysis for the relative intensity of G6PD, NeuN, GFAP, and Iba-1 in single cells in the hippocampus CA3 region of epileptic mice at 28 d after KA injection (n = 50 cells from nine sections of each group, from three mice). Data are presented as means ± SEM. ***P < 0.001, unpaired two-tailed Student’s t-test.
Techniques Used: Immunostaining, Binding Assay, Injection, Two Tailed Test
Figure Legend Snippet: Fig. 4. G6PD negatively regulates the expression of N-methyl-D-aspartic acid receptors (NMDARs) through increasing STAT1 (a) RNA sequencing revealed that G6PD increased the transcription of Stat1 in epileptic mice. (b–e) Representative immunoblots (b, d) and quantification (c, e) of total STAT1 (n = 6), STAT3 (n = 6), p- STAT1 (n = 3), and nuclear STAT1 (n = 6) expression in the hippocampi of mice from the adCtrl and adG6PD groups. (f–i) Representative immunoblots (f, h) and quantification (g, i) of total and surface protein expression of NMDARs in the mouse hippocampus from the adCtrl and adG6PD groups (n = 6). Data are presented as means ± SEM. **P < 0.01, ***P < 0.001, unpaired two-tailed Student’s t-test. (j) Effect of G6PD overexpression on the number of daily spontaneous recurrent seizures in the adCtrl, adG6PD, and adG6PD + fludarabine groups (n = 8). Data are presented as means ± SEM. ***P < 0.001, one-way ANOVA with Tukey’s post- hoc test. (k–l) Representative immunoblots (b) and quantification (c) of NMDARs (Glu2A, Glu2B, and GluN1) in the hippocampi of mice in the adCtrl, adG6PD, and adG6PD + fludarabine groups (n = 6). Data are presented as means ± SEM. *P < 0.05, ***P < 0.001, one-way ANOVA with Tukey’s post-hoc test.
Techniques Used: Expressing, RNA Sequencing, Western Blot, Two Tailed Test, Over Expression
Figure Legend Snippet: Fig. 5. G6PD promotes the expression of STAT1 by decreasing reactive oxygen species (ROS) (a–d) Quantification of ROS, NADPH/NADP+, and GSH/GSSH in the control, AG1, AG1+DMF, 6-An, and 6-An + NAC groups after kainic acid (KA) treatment of HT22 cells. Data are presented as means ± SEM. ****P < 0.0001, one- way ANOVA with Tukey’s post-hoc test. (e–h) Quantification of ROS, NADPH/NADP+, and GSH/GSSH in the control, 6-An, 6-An, 6-An, and 6-An + NAC groups after kainic acid (KA) treatment of HT22 cells. Data are presented as means ± SEM. ****P < 0.0001, one-way ANOVA with Tukey’s post-hoc test. (i–i) Representative immunoblots (i) and quantification (j) of STAT1 in agonist (Con, AG1, and AG1+DMF groups) and inhibitor (Con, 6-An, and 6-An + NAC groups) groups after KA treatment of HT22 cells. Data are presented as means ± SEM. **P < 0.01, ***P < 0.001, one-way ANOVA with Tukey’s post-hoc test.
Techniques Used: Expressing, Control, Western Blot
Figure Legend Snippet: Fig. 6. Transcription factors Znf768 and Klf6 regulate G6PD expression. (a) Quantitative real-time polymerase chain reaction analysis of predicted transcription factors (n = 4). Data are presented as means ± SEM, ns P > 0.05, **P < 0.01, nonsignificant unpaired two-tailed Student’s t-test. (b–c) Representative immunoblots (b) and quantification (c) of ZNF768 and KLF6 from the hippocampus of sham and chronic epileptic mice (n = 6). Data are presented as means ± SEM, **P < 0.01, ***P < 0.001, unpaired two-tailed Student’s t-test. (d) Relative luciferase activities in HEK293 cells. Cells were transiently co-transfected G6pd with vector or Znf768 or Klf6 (n = 6). Data are presented as means ± SEM, **P < 0.001, unpaired two-tailed Student’s t-test.
Techniques Used: Expressing, Real-time Polymerase Chain Reaction, Two Tailed Test, Western Blot, Luciferase, Transfection, Plasmid Preparation
Figure Legend Snippet: Fig. 7. The G6PD activator AG1 alleviates seizure susceptibility (a) Example traces matching the minimal and tonic-clonic seizures of PTZ-injected mice. Scale bars, 0.3 mV and 1 s. (b) Timeline of 6-An and AG1 injection before the administration of pentylenetetrazol (PTZ) (12.5 mg/kg PTZ was injected into C57BL/6 mice once every 10 min, up to 10 times). (c) The seizure susceptibility in the sham and 6-An group following the injection of PTZ (n = 8). Data are presented as means ± SEM, **P < 0.01, unpaired two-tailed Student’s t-test. (f, g) Immunoblot images and statistical analysis of hippocampal G6PD after AG1 administration (n = 4). Data are presented as means ± SEM. *P < 0.05, one-way ANOVA with Tukey’s post-hoc test. (h, i) The seizure susceptibility in the sham and AG1 groups following the injection of PTZ (n = 8). Data are presented as means ± SEM, *P < 0.05, unpaired two-tailed Student’s t-test.
Techniques Used: Injection, Two Tailed Test, Western Blot
Related Articles
Injection:Article Title: Glucose-6-phosphate dehydrogenase alleviates epileptic seizures by repressing reactive oxygen species production to promote signal transducer and activator of transcription 1-mediated N-methyl-d-aspartic acid receptors inhibition. Article Snippet: .. For Article Title: Glucose-6-phosphate dehydrogenase alleviates epileptic seizures by repressing reactive oxygen species production to promote signal transducer and activator of transcription 1-mediated N-methyl-d-aspartic acid receptors inhibition Article Snippet: .. For |